Cargando…
Unlocking the Therapeutic Potential of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination for the Pathogenesis of Atherosclerosis in Type 2 Diabetes
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Endocrine Society
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937850/ https://www.ncbi.nlm.nih.gov/pubmed/33677927 http://dx.doi.org/10.3803/EnM.2021.109 |
| _version_ | 1783661477223202816 |
|---|---|
| author | Son, Jang Won |
| author_facet | Son, Jang Won |
| author_sort | Son, Jang Won |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7937850 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Korean Endocrine Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79378502021-03-15 Unlocking the Therapeutic Potential of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination for the Pathogenesis of Atherosclerosis in Type 2 Diabetes Son, Jang Won Endocrinol Metab (Seoul) Editorial Korean Endocrine Society 2021-02 2021-02-24 /pmc/articles/PMC7937850/ /pubmed/33677927 http://dx.doi.org/10.3803/EnM.2021.109 Text en Copyright © 2021 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Son, Jang Won Unlocking the Therapeutic Potential of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination for the Pathogenesis of Atherosclerosis in Type 2 Diabetes |
| title | Unlocking the Therapeutic Potential of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination for the Pathogenesis of Atherosclerosis in Type 2 Diabetes |
| title_full | Unlocking the Therapeutic Potential of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination for the Pathogenesis of Atherosclerosis in Type 2 Diabetes |
| title_fullStr | Unlocking the Therapeutic Potential of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination for the Pathogenesis of Atherosclerosis in Type 2 Diabetes |
| title_full_unstemmed | Unlocking the Therapeutic Potential of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination for the Pathogenesis of Atherosclerosis in Type 2 Diabetes |
| title_short | Unlocking the Therapeutic Potential of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination for the Pathogenesis of Atherosclerosis in Type 2 Diabetes |
| title_sort | unlocking the therapeutic potential of glucagon-like peptide-1 analogue and fibroblast growth factor 21 combination for the pathogenesis of atherosclerosis in type 2 diabetes |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937850/ https://www.ncbi.nlm.nih.gov/pubmed/33677927 http://dx.doi.org/10.3803/EnM.2021.109 |
| work_keys_str_mv | AT sonjangwon unlockingthetherapeuticpotentialofglucagonlikepeptide1analogueandfibroblastgrowthfactor21combinationforthepathogenesisofatherosclerosisintype2diabetes |